Labiana Health, S.A. (BME:LAB)
6.15
-0.05 (-0.81%)
At close: Sep 16, 2026
Labiana Health Company Description
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally.
It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products.
The company also provides sterile and lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name.
In addition, it offers contract development and manufacturing services. The company was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Labiana Health, S.A.
| Country | Spain |
| Founded | 1958 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 373 |
| CEO | Manuel Ortega |
Contact Details
Address: Av. Europa Pozuelo de Alarcón, 28023 Spain | |
| Phone | 34 919 91 26 28 |
| Website | labiana.com |
Stock Details
| Ticker Symbol | LAB |
| Exchange | Madrid Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | ES0105638003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Manuel Ramos Ortega | President, Chief Executive Officer and Chairman |
| Miquel Pujolriu Gimenez | Chief Financial Officer and Secretary of the Board |
| Cristina Ramos Recoder | Director of Investor Relations |
| Ivana Novoa | HR Director |
| Sandra Villagrasa Clemente | Executive Director |
| Xavier Perez Ramos | Managing Director of Animal Division |
| Dragoljub Milinkovic | Managing Director of Zavod |
| Suva Kaya | Managing Director of Zoleant |